Drug Treatment Obesity Navigation


Drug Treatment Obesity

|

Partners
Tell A Friend about us
Shepparton Drug Alcohol Treatment |
Information Of Alcohol |
Drug Rehab In Hattiesburg Ms |
Alcohol Treatment Fda |
Article On Substance Abuse |
Synlock Chemical Dependency Counsil Jonesville, La |
Alcohol Treatment Christian |
Drug Treatment Group Topics |
Alcohol Treatment Techniques |
Drug Treatment Utah |
Inpatient Alcohol Treatment |
Alcohol Treatment Resorts |
Orlando Drug Alcohol Treatment |
Wrexham Maelor Drug Alcohol Treatment |
Substance Abuse Policies For Employees Canada |

List of Drug-Alcohol-Treatment Articles

Drug Treatment Obesity Best Seller



Best Drug Treatment Obesity Products

Social bookmarking
You like it? Share it!
socialize it


Main Drug Treatment Obesity Sponsors


Drug Treatment Obesity

 

Latest Drug Treatment Obesity Link Added

Top 5 Drug and Alcohol Treatment Pages

1. Drug Rehab
2. Drug Alcohol
3. Drug Treatment
4. Drug Addiction
5. Alcohol Treatment




Submit your link on Drug Treatment Obesity!


Welcome to Drug and Alcohol Treatment


 

Drug Treatment Obesity Article

Thumbnail example

This is a selection made from among articles on Drug Treatment Obesity. For a permanent link to this article, or to bookmark it for future reading, click here.

from: Drug Rehab Chronicles - Alcohol Addiction Can Strike Anyone, Even A Genius




Drug Rehab Chronicles - Alcohol Addiction Can Strike Anyone, Even A Genius
By Rod MacTaggart




For every person who needs a successful alcohol and drug rehab program, there are millions who never get started. Charlie Frazer was one of them.



A popular jazz musician, Charlie, was a friendly and outgoing young man without the huge ego one expects of a truly talented player. Charlie was generous with himself and his talents, sharing musical insights and advice with musicians and fans who frequented the jazz clubs where he played bass with a popular quintet. And as local custom dictates, Charlie’s admirers rewarded him with rounds of drinks. And Charlie always accepted, and drank, and drank and drank. No one suspected that Charlie was unusually sensitive to alcohol, and had his own private demons as well – a prime candidate for alcohol addiction and abuse. Nor did they suspect how badly he needed to admit himself into an alcohol and program.



His band members were the first to notice it. Slight lapses in memory, sloppy playing, coming late to the job. Charlie assured them it was just a couple of shots to relax, not to worry. But his bass playing got worse, and his relationship with the guys in the band deteriorated. There were arguments, promises and apologies – but nothing got resolved. Charlie drank afternoons, evenings and through to dawn. When his mates suggested an alcohol and drug rehab program to help with his obvious alcohol abuse, Charlie laughed it off, insisting there was no need for anything so serious.



Alcoholics are self-delusional about their alcohol addiction and abuse. In fact, that’s one of the major reasons they don’t enter alcohol or drug rehab to get help. It can take a lot to break through the veneer of lies and deception and see the real situation. For Charlie, the opportunity for such a moment of truth came on opening night at the city’s most prestigious jazz venue, the Jazz Tavern, the band’s most important gig to date. Everyone who was anyone in the jazz world was there – famous musicians, critics from the media, a movie star or two and dozens of fans. Predictably, Charlie arrived drunk, and the band warily launched into the first number. During the second chorus, everything unraveled. While patrons watched in horror, Charlie staggered, fell off the stage, and crash-landed in the center of a ringside table, out cold and still holding his bass. The shocked audience didn’t know whether to laugh or cry.



No one at the table was injured, and Charlie revived enough to be led outside and sent home in a cab. After the dust settled, a local bass player in the audience stepped up and finished the gig – not a total loss. But for the band, and especially for Charlie, the shine was off the gold.



Over the next few days, band mates, friends and family urged Charlie to get into an alcohol and drug rehab program. But Charlie’s moment of truth had come and gone, unrecognized. He brushed it all off as a hugely amusing, if unfortunate, incident, and kept on drinking. Within weeks, the band had broken up. Charlie found it difficult to get work. A few shorts months later, Charlie could be found in the seedier sections of the city panhandling for money, or hanging around jazz clubs hoping to score a few dollars for booze.



Within a year or two, not many jazz fans remembered Charlie Frazer. His fellow musicians talked about him in the past tense, as if he had died. And in fact, as a musician, he had. Working part-time in construction, drinking every night and still denying to himself and anyone who cared to listen that he had a problem, Charlie Frazer had become another tragic statistic, a victim of alcohol abuse. And another person who’s future would have been far different had he gone to a successful alcohol and drug rehab program



drug rehab program




Rod MacTaggart is a Florida-based freelance writer who contributes articles on health.



Contact: info@drugrehabreferral.com



To find a successful drug rehab program http://www.drugrehabreferral.com



Article Source: http://EzineArticles.com/?expert=Rod_MacTaggart
http://EzineArticles.com/?Drug-Rehab-Chronicles---Alcohol-Addiction-Can-Strike-Anyone,-Even-A-Genius&id=629697









Drug Treatment Obesity Specific links

Drug Treatment Obesity News

Novo obesity drug seen with 43 percent chance of approval

COPENHAGEN (Reuters) - Danish group Novo Nordisk's diabetes drug Victoza has a 43 percent chance of being approved as an obesity treatment in the United States, according to a Reuters poll which found Danish bank analysts had the highest expectations. Novo Nordisk, the world's biggest insulin producer, is in phase three of studies to use Victoza to treat obesity and expects the treatment to be ...

Read more...


US panel gives nod to new obesity drug

A panel of experts on Thursday urged US regulators to approve what could be the first new anti-obesity drug on the market in more than a decade -- Lorcaserin, made by Arena Pharmaceuticals.

Read more...


Double-drug diabetes treatment disappoints in kids

NEW YORK (Reuters Health) - In a large new trial looking at ways to slow the progression of type 2 diabetes in children and teens, the addition of a second drug to the mainstay treatment metformin was only marginally more effective at controlling blood sugar than metformin alone. ...

Read more...


U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012

NEW YORK, May 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012   ...

Read more...


New Anti-Obesity Drug Approved By Expert Panel

A panel voted 18 to 4 in favor of approving the new anti-obesity drug Lorcaserin for use on the drug market. The drug works to control the appetite through receptors in the brain, and a study showed it helped nearly half of participants lose up to five percent of their body weight. The Food and Drug Administration is scheduled to decide on June 27 whether the drug should be approved for use in ...

Read more...


Obesity Drug Lorcaserin Gets Positive Vote From FDA Panel

Lorcaserin, an investigational obesity drug, was given a positive recommendation by the Endocrinologic and Metabolic Drugs Advisory Committee, which advises the Food and Drug Administration (FDA). The Committee voted 18 to 4 in favor, with one abstention, in advising the FDA whether to approve the medication for obese or overweight individuals. The majority of the members of the Committee found ...

Read more...


US FDA staff focus on safety of Arena obesity pill

WASHINGTON (Reuters) - U.S. drug reviewers on Tuesday said Arena Pharmaceuticals Inc's obesity pill appeared to help people lose weight and was unlikely to cause tumors in humans, but questioned if the company had provided enough data to rule out heart problems. Lorcaserin is one of three new potential obesity treatments vying to gain U.S. approval and be the first new weight-loss treatment on ...

Read more...


Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years

NEW YORK, NY-- - Biotech companies are looking to cash in on the anti-obesity drug market. The race to bring the first weight-loss pill to the market is heating up as Arena Pharmaceuticals weight-loss ...

Read more...


Arena Says Obesity Drug Candidate Receives Positive Vote From FDA Advisory Panel

Arena Says Obesity Drug Candidate Receives Positive Vote From FDA Advisory Panel

Read more...


Arena Still Faces A Fight On Obesity Drug Approval

FDA briefing documents are generally positive for lorcaserin, a weight loss drug, but big hurdles remain.

Read more...